This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Vijaya Pattabiraman, PhD
Co-founder and CTO at Bright Peak Therapeutics
Speaker

Agenda Sessions

  • BPT567 (PD1-IL18), A Next-Generation PD1-based Immunoconjugate: From Platform to Patients

    , 09:00
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Vijaya at Antibody Engineering & Therapeutics Europe

BOOK NOW